| Literature DB >> 35331320 |
Rosa Marie Kiil1,2,3, Clara E Mistegaard4,5, Anne Gitte Loft6,5, Anna Zejden7, Oliver Hendricks4,8, Anne Grethe Jurik7,6,4.
Abstract
BACKGROUND: Early diagnostics of axial spondyloarthritis (axSpA) remains a challenge. Traditional imaging one-plane sacroiliac joint (SIJ) MRI assessment is used. By introducing a two-plane assessment system, the objective was to analyse the differences in SIJ MRI changes in early axSpA compared with changes in patients with mechanical back pain (MBP) by exploring the differences in volume and location.Entities:
Keywords: Back pain; Imaging; Magnetic resonance imaging (MRI); Spondyloarthritis
Mesh:
Year: 2022 PMID: 35331320 PMCID: PMC8944150 DOI: 10.1186/s13075-022-02760-7
Source DB: PubMed Journal: Arthritis Res Ther ISSN: 1478-6354 Impact factor: 5.156
Demographic, biochemical and clinical data. N (%) if not otherwise stated
| axSpA ( | MBP ( | |
|---|---|---|
| Male gender | 15 (60%)* | 19 (32%) |
| Age (years), mean (SD) | 31.6 (5.7) | 32.3 (5.8) |
| HLA-B27 positivity | 18 (72%)* | 11 (19%) |
| BMI (kg/m2), mean (SD) | 26.4 (4.2) | 26.5 (4.4)a |
| Childbirths (number), mean (SD) if female ( | 1.6 (1.1) | 1.7 (1.2) |
| Time since last childbirth (years), mean (SD) ( | 5.3 (4.2) | 4.0 (4.2) |
| Fulfilment of the 2009 ASAS criteria [ | 24 (96%)* | 36 (61%) |
| Sacroiliitis according to the 2009 ASAS criteria [ | 24 (96%) | 49 (83%) |
| Inflammatory back pain (ASAS definition [ | 20 (80%)* | 30 (51%) |
| Buttock pain | 23 (92%)* | 41 (69%) |
ASAS Assessment of SpondyloArthritis International Society, axSpA axial spondyloarthritis, BMI body mass index, HLA-B27 human leucocyte antigen subtype B27, N number, SD standard deviation
*p < 0.05 for test for between-group differences
an = 57
The mean axial spondyloarthritis (axSpA) confidence scores for the likelihood of axSpA ranging between − 5.0 and 5.0 in MBP and axSpA patients based on MRI assessment only. N (%) if not otherwise stated
| axSpA ( | MBP ( | |
|---|---|---|
| − 5.0 to − 3.0 | 4 (16%) | 36 (61%) |
| − 2.5 to − 0.5 | 4 (16%) | 12 (20%) |
| 0 | 2 (8%) | 4 (7%) |
| 0.5 to 2.5 | 2 (8%) | 2 (3%) |
| 3.0 to 5.0 | 13 (52%) | 5 (8%) |
axSpA axial spondyloarthritis, MBP mechanical back pain, N number
Fig. 1A, B Prevalence and sumscores of BME in the 12 cartilaginous and two ligamentous joint portions in axSpA (A) and MBP (B) patients divided in the iliac (left) and sacral (right) sides. C, D BME depth prevalence in the same locations and patient groups as in A and B. Boxes in A and B represent the prevalence and relative sumscore, whereas boxes in C and D represent the BME depth prevalence in each location
Fig. 2A, B Prevalence of FMD in the six cartilaginous joint portions in axSpA (A) and MBP (B) patients divided in iliac the (left) and sacral (right) sides. C, D Prevalence of FMD depth in the same locations and patient groups as in A and B. Boxes represent the prevalence in each location
Fig. 3A, B Prevalence of sclerosis in the six cartilaginous joint portions in axSpA (A) and MBP (B) patients divided in the iliac (left) and sacral (right) sides. C, D Prevalence of erosions in the same locations and patient groups as in A and B. Boxes represent the prevalence in each location
Prevalence of four atypical SIJ morphologies, transitional vertebra and disc degenerative changes. Furthermore, BME and/or structural changes in relation to these. N (%) if not otherwise stated
| axSpA ( | MBP ( | |
|---|---|---|
| Any atypical SIJ morphology | 20 (80%) | 53 (90%) |
| Accessory SIJ | 9 (36%) | 27 (46%) |
| With BMEa | 6 (67%) | 7 (26%) |
| With structural changesb | 4 (44%) | 9 (33%) |
| Iliosacral complex | 15 (60%) | 35 (59%) |
| With BMEa | 10 (67%) | 5 (14%) |
| With structural changesb | 5 (33%) | 1 (3%) |
| Dysmorphic cartilaginous facets | 10 (40%) | 22 (37%) |
| With BMEa | 10 (100%) | 18 (82%) |
| With structural changesb | 9 (90%) | 9 (41%) |
| Bipartite iliac bony plate | 1 (4%)* | 15 (25%) |
| With BMEa | 0 | 1 (7%) |
| With structural changesb | 0 | 0 |
| Transitional vertebra | 2 (8%) | 3 (5%) |
| With BMEa | 2 (100%) | 1 (33%) |
| With structural changesb | 2 (100%) | 3 (100%) |
| Disc degeneration (0–3) | 1.6 | 1.7 |
| Disc extrusion (disc degeneration = 3) | 6 (24%) | 16 (27%) |
| Vertebral corner changes (BME/FMD) | 3 (12%)* | 1 (2%) |
| Vertebral end plate changes (BME/FMD) | 6 (24%) | 20 (34%) |
axSpA axial spondylarthritis, BME bone marrow edema, MBP mechanical back pain, N number, SIJ sacroiliac joint
*p < 0.05 for the test for between-group differences
a Percent of atypical morphologies accompanied by BME
b Percent of atypical morphologies with structural changes in form of FMD and/or sclerosis in relation to an atypical morphology
Univariate logistic and, when appropriate, linear regressions of the association between MRI patterns and axSpA diagnosis, anatomical sacroiliac joint variations, gender, childbirths, age and body mass index. Odds radios (confidence intervals) if other not stated
| axSpA | acc SIJ | ISC | Dysm CF | BIBP | Extrusion | Gender | Childbirths | Agea | BMIa | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.6 (0.2–1.8) | 0.5 (0.2–1.3) | 0.6 (0.2–1.4) | 0.6 (0.2–1.7) | 1.0 (0.3–3.2) | 1.8 (0.7–5.1) | 0.5 (0.2–1.5) | 1.4 (0.6–3.6) | 0.0 (− 2.7–2.7) | − 1.1 (− 3.2–0.9) | |
| 2.0 (0.7–5.8) | 1.4 (0.5–3.4) | 1.6 (0.7–4.1) | 2.0 (0.8–5.4) | 1.2 (0.4–3.9) | 0.4 (0.2–1.1) | 1.5 (0.6–3.7) | 0.8 (0.3–1.9) | − 0.8 (− 3.5–1.8) | 1.5 (− 0.4–3.5) | |
| 0.6 (0.2–2.1) | 0.3 (0.1–1.0) | 0.8 (0.3–2.3) | 2.8 (0.9–9.2) | 1.1 (0.3–3.6) | 0.9 (− 2.1–4.0) | − 0.6 (− 2.9–1.7) | ||||
| 1.4 (0.6–3.5) | 0.8 (0.3–1.9) | 0.8 (0.3–2.0) | 0.8 (0.3–2.7) | 0.5 (0.2–1.4) | 1.6 (0.7–4.1) | 1.0 (0.4–2.6) | − 0.8 (− 3.4–1.8) | 1.9 (− 0.1–3.9) | ||
| 0.6 (0.2–2.1) | 1.4 (0.5–4.1) | 1.5 (0.5–4.4) | 1.4 (0.5–4.0) | 1.3 (0.4–4.6) | 0.1 (0.0–1.0) | 2.0 (0.7–5.8) | − 1.7 (− 4.8–1.3) | − 0.8 (− 3.1–1.6) | ||
| 1.4 (0.4–4.3) | 0.7 (0.2–2.0) | 2.6 (0.8–8.9) | 1.6 (0.5–4.7) | 3.1 (0.9–10.3) | 0.5 (0.1–2.1) | 1.2 (− 2.9–4.3) | 2.2 (− 0.1–4.5) | |||
| 2.6 (0.9–7.9) | 0.3 (0.1–1.1) | 1.0 (0.3–2.8) | 2.2 (0.7–6.3) | 1.4 (0.4–5.1) | 0.5 (0.1–2.1) | 1.8 (0.6–5.1) | − 0.5 (− 3.7–2.6) | − 1.1 (− 3.5–1.3) | ||
| 1.5 (0.5–4.0) | 1.0 (0.4–2.9) | 0.6 (0.2–1.8) | 0.4 (0.1–1.9) | 0.2 (0.1–1.2) | 0.9 (0.3–2.4) | − 1.3 (− 4.2–1.6) | 1.2 (− 1.0–3.4) | |||
| 1.9 (0.8–4.8) | 0.9 (0.3–2.2) | 1.3 (0.4–3.9) | 0.4 (0.1–1.2) | 1.4 (0.6–3.6) | 1.2 (0.5–2.9) | 1.3 (− 1.4–3.9) | 1.4 (− 0.6–3.4) | |||
| 0.7 (0.3–1.8) | 1,2 (0.5–3.2) | 1.0 (0.3–3.1) | 0.4 (0.1–1.3) | 1.0 (0.4–2.6) | 0.8 (0.4–2.1) | 0.2 (− 2.5–2.9) | 0.0 (− 1.1–3.1) | |||
| 1.2 (0.5–3.1) | 2.0 (0.7–5.5) | 1.6 (0.6–4.1) | 0.8 (0.2–2.8) | 0.3 (0.1–1.2) | 1.4 (0.5–3.5) | 0.9 (0.4–2.3) | 0.1 (− 2.7–2.9) | 1.0 (− 1.1–3.1) |
Acc SIJ accessory sacroiliac joint, axSpA axial spondyloarthritis, BIBP bipartite iliac bony plate, BME bone marrow edema, BMI body mass index, dysm CF dysmorphic cartilaginous facets, extrusion lumbar disc extrusion, FMD fatty marrow deposition, ISC iliosacral complex
*p < 0.05
aLinear regressions and results reported as regression coefficients (confidence intervals)